Review Article
Transition Metal Complexes as Quantum Dots: Excellent alternatives to Organic Chromophores for Biological Imaging Applications
Prakash Kinthada*
Corresponding Author: Prakash Kinthada, Department of Chemistry, NIET, National Institute of Medical Science (NIMS) University, Jaipur, Rajasthan, India
Received: April 01, 2020; Revised: April 06, 2020;
Citation: Kinthada P. (2020) Transition Metal Complexes as Quantum Dots: Excellent alternatives to Organic Chromophores for Biological Imaging Applications. J Genomic Med Pharmacogenomics, 6(1): 425-432.
Copyrights: ©2020 Kinthada P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share :

In recent years, different types of inorganic nanoparticles (iNPs) with unique physicochemical properties have emerged. Among these, quantum dots (QDs) have proved to be very versatile, finding applications in electroluminescent displays, quantum computing, photovoltaics, solar cells, transistors and biological imaging. For biological imaging applications, QDs are now excellent alternatives to organic chromophores, given that they can have similar sizes, shapes and surface functional groups. A potentially prolific new direction in inorganic chemistry and nano chemistry could be to combine NPs with small metal complexes to seek synergistic and/or cooperative effects. In this context, combining QDs with coordination complexes is being explored as a new strategy to obtain cooperative systems with improved properties for applications in sensing, biological imaging and molecular therapy. A prominent area of research in coordination chemistry is the development of metal complexes that can act as artificial nucleases. Overall, these synthetic DNA-cleaving reagents operate using one of two distinct mechanisms.


Keywords: Quantum dots, Nano medicine, Coordination compounds, Transition metal complexes


Quantum dots are tiny semiconductor particles a few nanometres in size having optical and electronic particles that differ from large particles due to quantum mechanics. Their broad excitation bands are mainly helpful in their applications. Quantum dots are excellent alternatives to organic chromophores, given that they have similar sizes, shapes and surface functional groups.


In recent years, different types of inorganic nanoparticles (iNPs) with unique physicochemical properties have emerged. Among these, quantum dots (QDs) have proved to be very versatile, finding applications in electroluminescent displays, quantum computing, photovoltaics, solar cells, transistors and biological imaging.

Useful physicochemical properties of QDs

Their broad excitation bands with very high extinction coefficients and narrow emission bands that can be tuned across a region of the visible or near-infrared spectrum by varying the size and composition of the QD with high photo stability. For biological imaging applications, QDs are now excellent alternatives to organic chromophores. Given that they can have similar sizes, shapes and surface functional groups. In this context, some studies have shown that nanosized QDs can be considered generic curved surfaces that DNA can wrap around. This is important because bending may open and close certain sites along the double helix, making certain regions of the DNA more or less accessible. Potentially, this could have widespread implications and applications because it could lead to artificial regulation of a wide array of cellular processes for therapeutic and biotechnological applications, much like protein-DNA interactions do naturally.

In addition to enabling different applications, the effects of DNA-QD interactions need to be considered also from a toxicological point of view. However, there are contradictory reports concerning the ability of QDs to damage DNA in the absence and presence of light as well as their toxicity to cells. A potentially prolific new direction in inorganic chemistry and nanochemistry could be to combine NPs with small metal complexes to seek synergistic and/or cooperative effects. In this context, combining QDs with coordination complexes is being explored as a new strategy to obtain cooperative systems with improved properties for applications in sensing, biological imaging and molecular therapy.

A prominent area of research in coordination chemistry is the development of metal complexes that can act as artificial nucleases. Overall, these synthetic DNA-cleaving reagents operate using one of two distinct mechanisms:

(i) Oxidative scission of deoxyribose residues through redox chemistry and

(ii) Hydrolysis of the phosphodiester sugar backbone.

The most classical example of oxidative DNA-cleavage activity is exemplified by the Cu(II)-1,10-phenanthroline (1,10-phenantroline = phen) system, which has been utilized as a foot printing reagent for the evaluation of protein-DNA interactions as well as a probe for DNA and RNA secondary structure. In this intensively investigated system, [Cu(phen)2]+ generated in the presence of a reducing agent and molecular oxygen afford activated oxygen species for DNA cleavage, whereas the intercalation of phen into the DNA minor groove allows for DNA targeting.

Recently, we discovered that QDs cooperate and synergize with the Cu(II)-1,10-phenanthroline system for DNA cleavage, providing both the first example of cooperative DNA cleavage between NPs and a small-molecule-based synthetic metallonuclease and a potentially new approach to develop more efficient DNA-cleaving systems. Many ligand systems and approaches have been tested with varying degrees of success to increase both the DNA scission capability and the affinity of copper metallonucleases for DNA. A popular strategy is to use bimetallic agents because of the potential cooperative effects that can arise between the two metal centres. However, an emerging way to design more powerful synthetic catalysts for a wide range of transformations, including DNA cleavage, utilizes ligands with hydrogen bonding features resembling those found in the active sites of metalloenzymes. We have combined the advantages of dinuclear copper catalysts with those of hydrogen-bonding ligands, and we exploit QDs as a redox-active protein-like nanostructure to activate strongly the copper catalysts for DNA cleavage. Two novel (μ-guanazole)-bridged binuclear copper(II) complexes with 1,10-phenanthroline (phen) or 2,2-bipyridine (bipy), [Cu2(μ-N2,N4-Hdatrz)(phen)2(H2O)(NO3)4] (1) and [Cu2(μ-N1,N2-datrz)2(μ-OH2)(bipy)2]-(ClO4)2 (2) (Hdatrz = 3,5-diamino-1,2,4-triazole = guanazole), have been prepared and characterized by X-ray diffraction, spectroscopy and susceptibility measurements.

Two mono (phen)-CuII fragments have been attached in the same compound by means of a single μ-triazole bridge using the ligand guanazole (guanazole = 3,5-diamino-1,2,4-triazole = Hdatrz), thus yielding two copper centres with labile coordination sites of facile substitution and a structure suitable for DNA intercalation.

The analogous bipy (2, 2-bipyridine = bipy) ternary compound has been prepared, resulting in a dinuclear compound that contains a bis (guanazolate) bridge.

In addition to providing a bridge between the two copper centers, the X-ray crystal structures reveal that the guanazole/guanazolato provides NH groups for hydrogen-bonding interactions with the DNA. To effect DNA cleavage efficiently, these new copper complexes are combined with water-soluble micelles filled with CdSe-ZnS core-shell QDs.

From a biosafety point of view, phages should not possess genes associated with bacterial toxins, pathogenicity, antibiotic resistance or other types of virulence factors. Additionally, phages should also display a low potential to horizontal gene transfer (transduction). Therefore, the complete genome needs to be sequenced to determine whether bacteriophages are suitable to control pathogenic bacteria.

Synthesis of [Cu2(μ-Hdatrz)(phen)2(H2O)2(NO3)4]

An aqueous solution of Cu (NO3)2·2.5H2O (1.148 g, 5 mmol, 20 mL) was mixed with an aqueous solution of guanazole (0.248 g, 2.5 mmol, 5 mL). A green solution was formed to which an aqueous suspension of phenantroline·H2O (0.993 g, 5 mmol, 10 mL) was added dropwise. A dark turbidity was almost immediately observed.

After 2 h of stirring, a black-green precipitate was filtered off, and the resulting dark green solution was allowed to stand at room temperature covered with Parafilm. Within 1 month, a few large black-green crystals, not suitable for X-ray, appeared; they were separated by filtration.

Synthesis of [Cu2(μ-datrz)2(μ-OH2)(bipy)2](ClO4)2

An aqueous suspension of bipy (0.156 g, 1 mmol, 20 mL) was slowly added (drop by drop) to an equimolar aqueous solution of Cu (ClO4)2·6H2O (0.37 g, 1 mmol, 20 mL). To this mixture, an aqueous solution of guanazole (0.02 g, 0.25 mmol, 5 mL) was slowly added. The reaction mixture was stirred for 2 h. A light blue precipitate was formed and filtered off. The remaining dark green solution was allowed to stand at room temperature. After 1 day, dark green single crystals of 2 appeared.

Synthesis of micelles filled with QDs and SPIONs

Micelles core-shell CdSe-ZnS QD were synthesized, characterized and purified as described previously. The CdSe-ZnS QD have an average diameter of 5.2 nm (4.0 nm CdSe core diameter and 0.6 nm ZnS shell thickness). The MQDs were prepared by self-assembly process of PEGylated phospholipids around hydrophobic CdSe-ZnS core-shell QDs. The water-soluble micelles with encapsulated superparamagnetic iron oxide nanoparticles of 6 nm as core material were prepared in the same way.

DNA-Copper complex interaction studies

For QD-CT-DNA interaction studies, a working solution containing 600 nM QD in cacodylate buffer (0.1 M, pH 6.0) was prepared. The experiment entailed the addition of serial aliquots of a CT-DNA stock solution. After each addition, the samples were excited at 400 nm and emission was recorded between 580 and 700 nm.

Samples were treated as described above in the presence of MPA. To test for the presence of reactive oxygen species (ROS) generated during strand scission in the presence of QD, various reactive oxygen intermediate scavengers were added to the reaction mixtures.

In addition, a chelating agent of copper (I), neocuproine (100 μM) was also assayed. Samples were treated as described above in the presence of MQD. All of the results are the average of experiments performed at least in triplicate.


DNA-binding and DNA-cleavage properties

The study of the DNA-binding properties was carried out for 1 and 2 through a series of techniques: Thermal denaturation, viscosimetry and fluorescence-based assays. Both complexes were prepared and isolated as solid products and then dissolved in water for the biological experiments. The existence of the dinuclear unit of 1 and 2 in solution was tested by mass spectrometry.

DNA binding properties

The shift in melting temperatures (ΔTm) resulting from the association of 1 and 2 with CT-DNA. The ΔTm produced by 1 is high and notably larger than by 2 (20 vs. 5°C), which implies that the stabilization of the DNA double strand produced by 1 is more pronounced.

DNA cleavage activity

Mechanism of DNA cleavage and role of the QDs: To clarify the mechanism (i.e., oxidative vs hydrolytic) of the nuclease activity of complexes 1 and 2, electrophoresis assays with ROS scavengers. These findings signal the minor groove of the DNA as the nuclease binding site, but in compound 1, this specificity is lower than, for instance, in [Cu(phen)2]2+, presumably because 1 can interact through electrostatic interactions and hydrogen bonding when the minor groove is inaccessible (vide supra). In the presence of MQDs, a clear inhibitory effect was found for the superoxide scavenger Tiron, which indicates that the DNA damage produced under these conditions occurs by an oxidative mechanism. To identify further the chemical processes involved in the QD-mediated DNA-cleavage process, we carried out X-ray photoelectron spectroscopy (XPS) studies.


DNA binding and cleavage studies reveal that Transition Metal Complexes/compounds can be used as efficient nucleases because of the cooperative effect of the two Cu(II) centers and the guanazole ligand, which in addition to providing a bridge between the two metals can participate in hydrogen-bonding interactions. Of the two complexes, 1 shows the highest affinity for DNA and binds via intercalation of the phen ligands. In the presence of oxygen and micromolar concentrations of MPA or H2O2 as activators, only 1 is capable of causing DNA cleavage. However, in the presence of nanomolar concentrations of water-soluble QD-filled micelles, both systems are highly efficient at cleaving DNA.

Photoinduced electron transfer from PbS quantum dots to Cobalt (III) Schiff Base Complexes

Recent advances in the development of therapeutic antitumor and antiviral agents have focused on compounds that bind to the biological active site of an enzyme. Although these reversibly bound drugs are susceptible to nonspecific and potentially undesirable reactions, the success of transition metal therapeutics, such as cisplatin, has refocused efforts aimed at investigating new complexes in this broad class. This research has facilitated an improved understanding of the interactions between complex biological systems and inorganic coordination complexes. Strategies for designing prodrugs, drugs that are administered as inactive compounds but are triggered by some controllable stimulus, have exploited differences in biological environments, such as pH, redox status and protein expression in achieving a higher level of specificity and efficacy. Photoreduction of Platinum (IV) is started by colloidal quantum dots. The electron transfer (PET) following photoexcitation at 615 nm. The wavelength of light that initiates PET and subsequent Pt (IV) reduction is within a favorable range (600-1300 nm) for maximal tissue depth penetration for in vivo applications. QDs possess highly tunable electrochemical and spectroscopic properties with excitonic transitions in the low energy visible and near-infrared (NIR) regions.

QDs have high two-photon cross-sectional efficiencies that surpass those of traditional organic dyes. Properties such as water solubility, cellular uptake and selective accumulation in malignant tumors have been tuned to achieve superior biocompatibility.

These attributes make QDs favourable candidates as photosensitizers for accessing multiple redox states of metal-based therapeutics in prodrug designs. Cobalt (III) Schiff base [Co(III)-SB] complexes of the equatorial tetradentate ligand bis(acetylacetone)-ethylenediimine (acacen) are known to be potent inhibitors of a wide array of zinc-dependent proteins, including thermolysin, α-thrombin. Modification of the acacen backbone to incorporate biomolecular targeting moieties (such as oligonucleotides) has been shown to selectively target zinc finger transcription factors. Evidence suggests the inhibition activity is due to disruption of the protein structure by coordination of Co (III) to active-site histidine residues. This coordination event occurs via a dissociative ligand exchange and is strongly dependent on the nature of the axial ligands present on the Co (III)-SB complex.

Selective enzyme inhibition is observed when the axial positions are occupied by either sterically hindered 2-methylimidazole or labile amine ligands. In general, the coordination behavior of cobalt Schiff base complexes is dependent on the oxidation state of the metal ion. Because of the redox properties of cobalt, axial ligand coordination of Co (II)-SB complexes has an increased propensity for dissociation.


Several batches of NIR light absorbing PbS were synthesized. We selected PbS QDs. The Co (III)-SB complexes were synthesized and characterized according to literature. To prepare the PbS QD/Co (III)-SB complex samples, we transferred a methanolic solution of the Co(III)-SB complex into a scintillation vial and dried it under nitrogen before adding 1.4 × 105 M PbS QDs in CHCl3. The vial was shaken until the Co (III)-SB complex was dissolved and the solution was allowed to equilibrate for 24 h  before measurements were taken. In summary, It has been shown that that selective photoexcitation of PbS QDs within mixtures of the QDs and Co (acacen)(Im)2 increases the axial ligand reactivity of the Co (III)-SB complex. It is proposed that the mechanism for this observation is electron transfer from the PbS QDs to Co (III), given that

(i)                  The dissociation of axial ligands is a documented and well-understood consequence of reduction of Co (III) to Co (II) in this Co (III)-SB complex.

(ii)                Electron transfer from the bottom of the conduction band of PbS QDs of this size to Co (III) is energetically favorable by 100 meV while energy transfer is not thermodynamically possible.

(iii)              Addition of the Co (III)-SB complex to the QDs quenches their PL while exposure of the QDs to the acacen molecule without the redox-active Co(III) center does not quench their PL, and

(iv)               Increasing the reduction potential of the Co (III) center within the Co (III)-SB complex by changing the axial ligand makes the Co (III)-SB complex a less efficient quencher of the PL of the QDs.

We can improve the electronic coupling between the QD and the Co (III)-SB complex by using a QD coating that minimizes steric repulsion at the surface of the QD or by functionalizing the Co (III)-SB complex such that it can more closely approach the QD. Results of such studies offer a unique route for light activation of a Co (III)-SB protein inhibitor via NIR excitation and suggest that the development of inorganic therapeutic agents may be specifically coupled to a biologically active site by cooperative redox binding ligation. A new binding strategy of linking quantum dots (QDs) to magnetic nanoparticles (MNPs) using DNA interaction with metal coordination bonding was developed. Platinum was selected for binding QDs to DNA. This nanoconjugate acts as a new probe for diagnosis with its double modalities, fluorescence and magnetic property. Owing to the high quantum yield and excellent photostability, QDs have been intensively investigated as a new probe for bioimaging and biosensor applications. The high potential medical utility of QDs in the areas of imaging and diagnosis has led to extensive exploration of methods to functionalize these nanoparticles. This effort has generated improved methods for surface modification and bioconjugation of QDs with various bioactive molecules, including small molecules, DNA and antibodies and the employment of the functionalized QDs for visualizing biological events in vitro and in vivo. In addition, because of the excellent optical properties of QDs, they have been utilized in approaches to create novel biologically interesting nanoconjugate probes. Various probes of this type, exemplified by gold nanoparticle (AuNP)-QD conjugates, have been devised to detect specific DNA, RNA and peptides, as a part of new techniques for cancer diagnosis. Nanomaterials comprised of conjugates between MNPs and QDs, which have both fluorescent and magnetic properties, have been investigated in the context of tools for the diagnosis of multiple cancers. A new strategy has been explored for binding QDs and MNPs taking advantage of metal coordination of DNA molecules as the key bonding component. This choice was inspired by platinum-based cisplatin, one of the most widely used anticancer drugs for the treatment of ovarian, testicular and head and neck cancers. The studies aimed at understanding the mode of action of this drug have shown that a cisplatin 1,2-intrastand d(GpG) cross link occurs on DNA to cause apoptosis of cancer cells. The central platinum (Pt)(II) of cisplatin, which possesses two ammonia and two chloride ligands coordinated with square planar geometry, forms stable coordination bonds with guanine N7 sites of DNA. Studies have shown that the nanoconjugates are more stable in vivo than are simple Pt complexes. Only a few approaches using strong coordination bonding character of the Pt (II) complex to generate nanoconjugates or nano assemblies have been reported.

It is known that the nature and specificities of reactions of metal-ligand complexes depend greatly on the properties of both the metal and chelating ligands. As a result, the strength of the coordination bond and the related ease of ligand substitution can be easily tuned using specific ligands. Studies would be aimed at developing a new approach for conjugating QDs and MNPs. Studies have used cis-dichlorobis-(dimethylsulfoxide)-platinum(II) (cis-PtII(DMSO)2Cl2), which contains a weakly bonded DMSO ligand that serves as a leaving group in a substitution reaction with a diamine, forming a (diamine)-QD–PtCl2 complex. The key proposal is that the N7 nitrogen of guanine bases in DNA linked MNPs would then substitute for the chloride ligands in the resulting complex to form a QD–Pt (II)–MNP–DNA nanoconjugate. Cd Se quantum dots are prepared by phosphorus-free methods using oleic acid as stabilizing surface ligand. Ligand exchange is monitored quantitatively by 1H NMR spectroscopy gives about 30 monodentate ligands per nanocrystal, with a ligand density of 1.82.3 nm2. The arrangement of nanosized objects into more complex structures remains a challenging target. One of the preconditions for such higher-level organization is the introduction of a limited number of attachment points. This offers the opportunity to link up spherical nanoparticles using covalent bonds or specific donoracceptor interactions to generate, for example, divalent or trivalent nanoparticles that can be the building blocks for linear or branched arrangements. We are especially interested in the functionalization of colloidal semiconductor quantum dots (QDs), in particular CdSe and were looking for ways of restricting the number of surface ligands by macrocyclic attachments, using coordination chemistry principles for the construction of stable nanocrystal-organic conjugates. The successful functionalization of nanoparticles requires an understanding of their surface chemistry. Semiconductor nanocrystals are stabilized by surfactant-type surface ligands which determine the growth rate, stability, and solubility of the nanocrystals.

While CdSe prepared using trioctylphosphine (TOP) and trioctylphosphine oxide (TOPO) are frequently represented with a surface coverage of TOPO, it is now known that the surface is mainly covered by TOP oxidation products, alkyl phosphinates and phosphonates, which coordinate to metal surface sites as bridging ligands. Nanocrystals prepared under phosphorus-free conditions using long-chain carboxylic acids such as stearic or oleic acid are stabilized by a layer of metal carboxylate. The nature of ligand binding has been explored mainly by NMR Spectroscopy, as well as luminescence and isotopic labelling methods. Macrocyclic compounds with a rigid aromatic framework, such as phthalocyanines, subphthalocyanines and porphyrins are synthetically readily accessible and can easily be derivatized to give compounds with a predetermined number of anchorpoints (usually 0-4). Hence, we propose to synthesize such macrocyclic molecules. Such ligands are expected to bind to nanocrystal surface sites by substitution of the surfactant ligands present from the synthesis stage. For a given concentration, due to the chelate effect polydentate ligands should bind to the surface of a nanocrystal significantly more strongly than monodentate ligands. We would focus on ligands of type subphthalocyanines  possess a cup-shaped structure, which suggested a good geometric match with nanocrystals with diameters in the 2-3 nm range; in addition they contain a functional group perpendicular to the macrocyclic core which offers the possibility of connecting to other ligand-decorated nanoparticles by covalent bonds. We will focus on porphyrins of this type which would be expected to act as monodentate ligands oriented perpendicular to the nanocrystal surface.

Although the central ring in porphyrins of this type is flattened, there is sufficient flexibility both in the ring and in the functionalized substituents X to allow these compounds to attach themselves to nanocrystals flat-on, i.e., parallel to the crystal surface. Alternatively, these ligands may adopt a perpendicular orientation bridging between two adjacent quantum dots. The structures and properties of the CdSe-macrocyclic constructs have been evaluated using a combination of 1HNMR, absorption and fluorescence spectroscopies.

Relative ligand binding strength

Oleic acid (octadec-9-enoic acid) possesses a cis-vinylene moiety which acts as a convenient 1H NMR marker. Preliminary qualitative experiments would be performed to establish the relative binding preference of carboxylic acids, phosphonic acids and thiols.

Number of ligands per nanoparticle

The number of oleate ligands per nanoparticle and hence the ligand density would be evaluated using a combination of UV-vis and 1H NMR spectroscopies.

Reactions of subphthalocyanines with CdSe QDs

In a series of initial reactions, the binding behavior of subphthalocyanine would be explored. This ligand is decorated with three meta-pyridyl substituents which give a bite angle that should be geometrically well-matched for binding to nanocrystals of 2-3 nm diameter, provided there are accessible Lewis acidic surface sites. Treatment of a solution of CdSe QDs in chloroform gave a deeply colored solution. Quenching of the QDs fluorescence was observed. The nanoparticles were precipitated with methanol, isolated by centrifugation and repeatedly washed with acetone until the washings were free of subphthalocyanine by UV/vis spectroscopy.

Reaction of metal-free porphyrin derivatives with CdSe nanoparticles

The interaction of pyridine-substituted free-base porphyrins as well as their metal complexes with CdSe and Cd/ZnS core-shell particles made by the TOPO route would be intensively studied, since we are interested in the interactions of carboxylate-type CdSe nanocrystals with carboxylate-substitutedporphyrins. Preliminary studies were carried out with 5,10,15,20-tetra(4-decyloxyphenyl) porphyrin which carries only alkyl substituents but no surface-binding functional groups. It quickly becomes evident that metal-free porphyrins become metalated in the presence of CdSe nanoparticles over time at room temperature. The insertion of Cd2+ into the ring system is evidenced by a visible color change; this was confirmed by the UV-vis spectra. The conversion of the metal-free into 5,10,15,20-tetra(4-decyloxyphenyl)-porphyrinato cadmium as a typical example.

Monodentate porphyrin ligands and CdSe nanoparticles

The binding of monodentate porphyrin ligands would be first examined

Tetradentate porphyrin ligands and CdSe nanoparticles

While monodentate porphyrin ligands were readily able to substitute oleate ligands, their steric requirements are moderate since they bind to the nanoparticle surface in “upright” position. Polydentate ligands, on the other hand, have the potential of covering large sections of the nanocrystal surface by lying flat and since we are interested in the question whether or not a nanoparticle could be essentially encapsulated by porphyrins and what binding mode would be adopted. The tetrasubstituted porphyrins are therefore synthesized.

Why Porphorins were chosen

Porphyrins were chosen due to the flexibility of the molecule. It is well-known that, in the case of tetraphenylporphyrins, the phenyl groups in the meso positions lie perpendicular to the tetrapyrrolic ring. Such a ligand is therefore able to bind parallel to the nanoparticle surface. Of course, the phenyl substituents are free to rotate, and suitable geometries will also be present.


CdSe nanocrystals were produced by a modification of a literature procedure. To cadmium oxide (300 mg, 2.34 mmol) in octadecene (20 mL) was added oleic acid (2 mL). The mixture was stirred under vacuum for 10 min, and then N2 was introduced. The mixture was heated to 250°C and stirred at this temperature until a clear solution was obtained, which was then left to cool to ca. 120°C. Selenium powder (100 mg, 1.27 mmol) was added and the mixture heated to 240°C, causing the color to change from yellow to orange. Heating was stopped when the color of the solution was deemed the right shade of orange for the desired nanocrystal size (after various experimental trials). The solution was immediately cooled on an ice bath, and toluene (10 mL) was added. The solution was then transferred to two large centrifuge tubes with filtration (syringe filter: 0.22 μL). The volume of both tubes was adjusted to 30 mL with toluene. The addition of acetone (20 mL) caused the formation of a white precipitate of unreacted starting material. The tubes were centrifuged (1400 rpm), the orange solutions were collected, and the white precipitate was discarded. The solution (25 mL) was again placed in a large centrifuge tube. Methanol (25 mL) was added, followed by centrifugation. An orange oil separated at the bottom, which was collected; the clear top solvent layer was discarded. This process was repeated until all the solution was processed in this way. The separated orange oils were combined and transferred to a smaller centrifuge tube with toluene (total volume 7 mL). Methanol (7 mL) was added and the tube centrifuged. Again, the orange oil was decanted. The volume was made up to 7 mL in dichloromethane, and the same volume of ethanol was added, followed by centrifugation. This process was repeated until a thick orange oil or powder was obtained. Finally, acetone (14 mL) was added, and the tube was sonicated for several minutes and then centrifuged. This was repeated five times. A free-flowing orange powder was finally obtained after drying under vacuum and stored under N2. Encapsulation of zinc-rifampicin complex into transferrin conjugated silver quantum dots improves its antimycobacterial activity and stability and facilitates drug delivery into macrophages.

In order to improve the chemotherapy of tuberculosis, there is an urgent requirement and hence synthesis of a novel anti TB drug complex consisting of zinc and rifampicin (ZnRIF) and encapsulated it into transferrin conjugated silver quantum dots (ZnRIFTf QD) to improve delivery in macrophages. Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tb), is one of the world’s major health problems. In combination chemotherapy, the “first line” therapy is of three or four drugs, i.e., isoniazid, rifampicin, pyrazinamide and ethambutol, followed by the less efficacious and more expensive “second line” drugs, which include capreomycin, kanamycin, amikacin, paraaminosalicylicacid, ciprofloxacin.

Metal ions have many important physiological functions in the body. Transition metal complexes exhibit unique and interesting properties such as changing oxidation states and the ability to form specific interactions with other biomolecules. It was shown that some metal drug complexes are more potent as compared to pure drug. Toward this end, the interactions of some antibiotics with transition metals have been studied. Among them, zinc is known to exhibit antibacterial activity. Zinc oxide (ZnO) nanoparticles are even more efficient along with reduced toxicity. Rifampicin (RIF), a broad-spectrum antibiotic, is one of the most effective first line drugs against TB. Semiconductor nanocrystals, also known as quantum dots (QDs), have become an important tool in biomedical research, especially for quantitative and long-term fluorescence imaging and detection. In view of this goal, we synthesized a zincrifampicin (ZnRIF) complex and checked its activity against non-pathogenic Mycobacterium smegmatis, and Mycobacterium bovis BCG, which behave like pathogenic M. tb. RIF is chosen since it coordinates with metal ions through chemical groups i.e. two phenolic and two aliphatic OH groups and the presence of additional nitrogen and oxygen donor atoms provide this compound interesting properties for studying its coordination behavior with transition metal ions.

Synthesis of ZnRIF complex and its conjugation to transferrin coupled QDs was studied by UV Visible Spectroscopy, Transmission Electron Microscopy (TEM), Fourier Transform Infrared Spectroscopy (FTIR), photoluminescence, X-ray diffraction (XRD), X-ray Fourier Transform Infrared Spectroscopy (FTIR) UVVis Spectra analysis of the ZnRIF complex Photoluminescence analysis of the ZnRIF complex X-ray photoelectron spectroscopy X-ray powder diffraction analysis of the ZnRIF complex go to: Photoelectron Spectroscopy (XPS), and Nuclear Magnetic Resonance (NMR). We observed that conjugation of ZnRIF complex to transferrin coupled QDs.


Fourier Transformation Infrared Spectroscopy (FTIR)

The structure of the ZnRIF complex was confirmed by several physicochemical methods. The IR spectrum of ZnRIF was compared with that of free RIF. In agreement with a previous report, the spectrum of free RIF showed characteristic peaks at3482 (OH), 2880,1726 (C=O), 1646(C=N), 1247(COC) and 808(CH) cm. A characteristic broad band at 3474 cm was observed with the synthesis and characterization of Zn-RIF complex.

1.       UV-Vis spectra analysis of the Zn-RIF Complex UV-V

2.       Photoluminescence analysis of the Zn-RIF

3.       X-ray photoelectron spectroscopy

4.       X-ray diffraction (XRD) analysis of ZnRIF COMPLEX

NMR spectroscopy1H

NMR spectrum analysis of RIF and the ZnRIF complex was carried out in DMSO-D6using a Bruker AVANCE 400 NMR spectrometer. Tetramethylsilane (TMS) was used as an internal standard. All peaks arising from unbound RIF ligand were clearly resolved with the phenolic hydroxyl protons appearing at 9-10 (2 H) ppm. In the ZnRIF spectrum these peaks were absent due to replacement with zinc. By comparing the splitting patterns, it can be concluded that the metal to ligand ratio is 1:1.

Characterization of ZnRIF complex

Transition metals can exhibit a wide variety of coordination properties and reactivities, which can be used to form complex with drugs as ligands. Previously, several studies have reported improved therapeutic properties of several metal complexes against M. tb. RIF, which is considered the cornerstone in the short course TB treatment regimen, exhibits detrimental side effects. To address these issues, we employed a strategy in which Zn was complexed with RIF to form a ZnRIF complex, which was subsequently encapsulated in transferrin conjugated silver QDs to yield the ZnRIFTf QD conjugate. Detailed physicochemical analyses confirmed the formation and encapsulation of ZnRIF complex in transferrin coupled QDs. We demonstrated that encapsulation of transferrin on the surface of quantum dots enhanced the binding efficiency of drug molecules. Then we showed that transferrin conjugated and ZnRIF encapsulated silver QDs successfully targeted to the macrophages, remaining stable for up to 48 h and significantly reducing the bacterial burden inside the macrophages.

Quantum dots (QDs) are nano scale semiconductor crystals with sizes of 1-10 nm. QDs provide excellent tools for sensing, imaging, drug delivery and therapy due to their optical properties, broad excitation range, well defined emission wavelengths and their ability to attain different shapes thus providing an excellent structure for coating with various biomolecules. Development of nanoscale drug delivery system that allows a slow release of drug over prolonged periods of time is important to thus avoid burst effects. Our results show that ZnRIFTf QDs meet these criteria.

For the synthesis of ZnRIF complex, 18 mg (0.095 mM) of hydrated zinc nitrate and 80 mg (0.097 mM). rifampicin in methanol and stirred for 3-4 h. The precipitate was dried, weighed and dissolved in dH O to do the experiments. ZnRIF complex was characterized by Fourier Transform Infrared Spectroscopy (FTIR) (Nicolet iS5, Thermo Scientific, India), UV Visible (Epoch, BioTek, Germany), X-ray photoelectron spectroscopy (XPS) (S/N: 10001, Prevac, Poland), Powder X-ray diffraction (XRD) (Shimatzu6100, Japan) and Nuclear Magnetic Resonance (NMR) (AVANCE 400, Bruker, Switzerland). Silver QDs were synthesized as described previously. Briefly, silver QDs were synthesized by reduction of silver nitrate (1 mM) by addition of excess of ice-cold sodium borohydride (2 mM) solution by vigorous stirring at room temperature. QDs were synthesized in less than a minute reaction time. The stoichiometric ratio of silver nitrate to sodium borohydride is very critical for the synthesis of QDs.

To synthesize ZnRIF encapsulated transferrin conjugated silver QDs, 1 mg/ml of transferrin and 500 μg/ml of ZnRIF complex were added together with 1 mM concentration of silver nitrate. Then the reaction mixture was reduced by excess ice-cold sodium borohydrate solution.

Characterization of ZnRIF encapsulated transferrin conjugated QDs (TfQDs) Cytotoxicity assay

RAW 264.7 cells (1 × 10 cells/well) were grown in 24 well plates for 24 h followed by treatment with different concentrations of drug complexes for another 24 h. Cell viability was determined by MTT assay as described previously.


Future scope and aims

DNA binding and cleavage studies reveal that Transition Metal Complexes/compounds can be used as efficient nucleases because of the cooperative effect of the two Cu (II) centres and the guanazole ligand, which in addition to providing a bridge between the two metals can participate in hydrogen-bonding interactions. Of the complexes, some show the highest affinity for DNA and binds via intercalation of the phen ligands. In the presence of oxygen and micromolar concentrations of MPA or H2O2 as activators, only some are capable of causing DNA cleavage. So, a large amount of studies can be done using this transition metal complexes as quantum dots. 

1.     Yi DK, Selvan T (2005) Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. J Am Chem Soc 127: 4990-4991.

2.     Sun YP, Zhou B (2006) Quantum-sized carbon dots for bright and colorful photoluminescence. J Am Chem Soc 128: 7756-7757.

3.     Sun YP, Fu KP (2002) Functionalized carbon nanotubes: Properties and applications. Acc Chem Res 35: 1096-1104.

4.     Juzhenas P (2008) Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Del Rev 60: 1600-1614.

5.     Tvrdy K, Kamat PV (2011) Photoinduced electron transfer from semiconductor quantum dots to metal oxide nanoparticles. Proc Natl Acad Sci 108: 29-34.

6.     Bijuand V, Otoh T (2008) Semiconductor quantum dots and metal nanoparticles: Syntheses, optical properties and biological applications. Anal Bioanal Chem 391: 2469-2495.

7.     Beverly A, Strobl JS (2009) Cadmium-containing nanoparticles: Perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharmacology 238: 280-288.

8.     Smit AM, Duan H (2008) Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Del Rev 60: 1226-1240.